AZGP1 Antikörper
Kurzübersicht für AZGP1 Antikörper (ABIN7265556)
Target
Alle AZGP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Zinc-α2-glycoprotein (ZAG/AZGP1) Rabbit mAb
-
Kreuzreaktivität
- Human, Ratte
-
Produktmerkmale
- Monoclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- A synthesized peptide derived from human Zinc-alpha2-glycoprotein (ZAG/AZGP1)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000,IHC,1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))
-
Andere Bezeichnung
- AZGP1
-
Hintergrund
- Zinc-α-2-Glycoprotein (AZGP1) can be found in blood plasma, seminal plasma, urine, sweat, saliva, liver, and epithelial cells of various human glands. AZGP1 has been proposed in the regulation of body weight, and the melanin production by normal and malignant melanocytes. AZGP1 stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. AZGP1 has been reported to stimulate lipid breakdown and may have an important role in lipid homeostasis. Mature human AZGP1 consists of one MHC class I antigen region and a C2-type Ig-like domain. AZGP1 has two alternate splice forms, one shows a 66 amino acids substitution for the C-terminal 30 amino acids, the other one shows a nine Lys substitution for amino acid 151-298.,ZA2G, ZAG,Cell Intrinsic Innate Immunity Signaling Pathway,Cytokines,Endocrine & Metabolism,Immunology & Inflammation,Lipid Metabolism,Signal Transduction,AZGP1
-
Molekulargewicht
- 43kDa
-
Gen-ID
- 563
-
UniProt
- P25311
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-